Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total	Series C Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance, (in shares) at Dec. 31, 2019	152,116,000
Beginning balance at Dec. 31, 2019	$ 519,163
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of Series C convertible preferred stock, net of issuance costs (in shares)		42,905,000
Issuance of Series C convertible preferred stock, net of issuance costs		$ 492,467
Repurchase of convertible preferred stock (in shares)	(547,000)
Repurchase of convertible preferred stock	$ (662)
Ending balance, (in shares) at Dec. 31, 2020	194,474,000
Ending balance at Dec. 31, 2020	$ 1,010,968
Beginning balance, (in shares) at Dec. 31, 2019			11,181,000
Beginning balance at Dec. 31, 2019	(111,108)		$ 1	$ 18,108	$ 454	$ (129,671)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock to strategic partners (in shares)			275,000
Issuance of common stock to strategic partners	1,004			1,004
Issuance of common stock for asset acquisition (in shares)			688,000
Issuance of common stock for asset acquisition	4,000			4,000
Issuance of common stock upon exercise of stock options (in shares)			113,000
Issuance of common stock upon exercise of stock options	373			373
Stock-based compensation (in shares)			5,345,000
Stock-based compensation	33,261		$ 1	33,260
Repurchase of convertible preferred stock	(3,582)			(3,582)
Repurchase of common stock (in shares)			(2,032,000)
Repurchase of common stock	(11,806)			(11,806)
Other comprehensive loss	(198)				(198)
Net loss	(204,472)					(204,472)
Ending balance, (in shares) at Dec. 31, 2020			15,570,000
Ending balance at Dec. 31, 2020	$ (292,528)		$ 2	41,357	256	(334,143)
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of convertible preferred stock to common stock (in shares)	(194,474,000)
Conversion of convertible preferred stock to common stock	$ (1,010,968)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)			2,750,000
Issuance of common stock upon exercise of stock options	9,442			9,442
Stock-based compensation (in shares)			4,944,000
Stock-based compensation	62,201			62,201
Proceeds from initial public offering, net of issuance costs (in shares)			25,000,000
Proceeds from initial public offering, net of issuance costs	391,802		$ 2	391,800
Conversion of convertible preferred stock to common stock (in shares)			194,474,000
Conversion of convertible preferred stock to common stock	1,010,968		$ 20	1,010,948
Other comprehensive loss	(1,879)				(1,879)
Net loss	$ (250,219)					(250,219)
Ending balance, (in shares) at Dec. 31, 2021	242,738,350		242,738,000
Ending balance at Dec. 31, 2021	$ 929,787		$ 24	1,515,748	(1,623)	(584,362)
Ending balance, (in shares) at Dec. 31, 2022	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	3,600,478		3,601,000
Issuance of common stock upon exercise of stock options	$ 9,577		$ 1	9,576
Stock-based compensation (in shares)			2,600,000
Stock-based compensation	81,924			81,924
Issuance of common stock under employee stock purchase plan (in share)			475,000
Issuance of common stock under employee stock purchase plan	1,519			1,519
Issuance of common stock in connection with restricted stock units, net of tax (in share)			153,000
Issuance of common stock in connection with restricted stock units, net of tax	(461)			(461)
Other comprehensive loss	(5,976)				(5,976)
Net loss	$ (183,118)					(183,118)
Ending balance, (in shares) at Dec. 31, 2022	249,567,343		249,567,000
Ending balance at Dec. 31, 2022	$ 833,252		$ 25	$ 1,608,306	$ (7,599)	$ (767,480)